News

February 02, 2016

Immuno-Oncology 360°

Imaging Endpoints CMO and Founder, Ronald Korn, MD., Ph.D. presents “Imaging the Immune System in Solid Tumors.”... full article

March 13, 2015

Radiogenomics should be an integral part of drug development, according to Dr Korn who talks to ecancer about this evolving field at TAT 2015.

July 03, 2014

TGen, Scottsdale Healthcare, and Cancer Centers of America are leading new research studies for patients suffering with lung cancer.

May 07, 2014

Boston, MA – May 7, 2014 – AG Mednet and the board-certified, fellowship-trained radiologists at Imaging Endpoints believe strongly that every clinical trial data point counts, from pre-clinical through FDA submission. To support its guarantee of accuracy, compliance, real-time reads and sponsor confidence, Imaging Endpoints is utilizing AG... full article

April 24, 2014

April 2014 - Ron Korn, MD, PhD, of Imaging Endpoints will be a featured presenter at Pharmatech's Biomarker Panel entitled "Development of Oncology Clinical Trials in the time of Precision, Personalized Medicine" occurring on May 15, 2014 at the Marriott San Francisco Waterfront. This event is a roundtable discussion with industry colleagues on... full article

April 18, 2014

April 2014 - Imaging Endpoints presents Poster at AACR 2014 in conjunction with Merrimack Pharmaceuticals and Virginia C. Piper Cancer Center. The Poster, entitled "Pilot study in patients with advanced solid tumors to evaluate feasibility of ferumoxytol (FMX) as a tumor imaging agent prior to MM-398, a nanoliposomal irinotecan (nal-IRI)"... full article

April 18, 2014

April 2014 - Imaging Endpoints presents Poster at AACR 2014 in conjunction with the University Of Arizona College Of Medicine, The Translational Genomics Research Institute (TGen) and The Virginia G. Piper Cancer Center. The Poster, entitled "Quantitative Textural Analysis (QTA) in CT imaging: identifying markers for genetic instability and... full article

April 18, 2014

April 2014 - Imaging Endpoints presents Poster at AACR 2014 in conjunction with RadioRx, Inc. and the University Of Arizona College Of Medicine. The Poster, entitled "RRx-001 Oxidation of Redox Sensitive Protein Thiols in Tumors Measured by Gd-LC7-SH Enhanced MRI in Preclinical Tumor Models" presents data from a pre-clinical study sponsored by... full article

Pages